Cytos Biotechnology
| Cytos Biotechnology AG
|
|
|---|---|
 |
|
| legal form | Corporation |
| ISIN | CH0011025217 |
| founding | 1995 |
| Seat | Schlieren , Switzerland |
| management | Christian Itin ( Chairman of the Board of Directors ) |
| Number of employees | 21 (December 31, 2012) |
| sales | 1.1 million CHF (2012) |
| Branch | Pharma , research |
| Website | www.cytos.com |
The Cytos Biotechnology AG is a biopharmaceutical company based in Schlieren , Switzerland . It was created in 1995 from a spin-off of the Swiss Federal Institute of Technology (ETH) in Zurich and is an independent company on the Swiss Exchange since October 2002 SIX Swiss Exchange listed .
Field of activity
Cytos Biotechnology specializes in the discovery , development and commercialization of a new class of biopharmaceutical preparations . These drugs , known as immunodrugs , are intended for use in the treatment and prevention of common chronic diseases . They are intended to activate the patient's immune system to generate desired therapeutic antibodies or T-cell reactions that modulate chronic disease processes.
In 2011, Cytos discontinued all projects that did not concern the great hope CYT003-QbG10 (for the treatment of allergic asthma and allergic rhinitis ) and reduced the workforce. Chairman of the management board , co-founder and largest shareholder Wolfgang Renner resigned and left the board of directors. Chairman of the Board of Directors Thomas Hecht took over operational management until Christian Itin was appointed Chairman of the Management Board in October 2012. At the end of 2012, there were still 21 full-time positions listed after 36 at the end of 2011. In April 2014, Cytos announced that CYT003 had proven ineffective; The management is now considering the closure and liquidation or bankruptcy of the company. The remaining employees would be fired.
Web links
Individual evidence
- ↑ a b Annual Report 2012 ( Memento of the original dated September 6, 2013 in the Internet Archive ) Info: The archive link was inserted automatically and has not yet been checked. Please check the original and archive link according to the instructions and then remove this notice.
- ↑ The former hope Cytos is fighting for survival in: Tages-Anzeiger from August 17, 2011
- ↑ Cytos decrees its shrinkage program - CEO Renner resigns in: Swissinfo of August 17, 2011
- ↑ Cytos Biotechnology AG announces strategic and organizational changes with the aim of maintaining the value of the lead product and looking for solutions with regard to the maturity of the convertible bond. ( Memento of December 11, 2011 in the Internet Archive ) Press release of August 17, 2011 (PDF).
- ↑ Cytos Biotechnology AG appoints Dr. Christian Itin as Chief Executive Officer. Media release of October 9, 2012 (PDF).
- ↑ Biotech company Cytos is about to end after the study has been canceled. blick.ch, April 14, 2014
